
Promimic Investor Relations Material
Latest events

ABGSC Investor Day 2023
Promimic

Q1 2025
15 May, 2025

Q4 2024
25 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Promimic
Access all reports
Promimic AB is a Sweden-based biomaterial company specializing in the development, manufacture, and sale of innovative biomaterials designed to enhance osseointegration, or bone healing. Their core technology revolves around a unique, nano-thin surface treatment, which is applied to various implant materials to improve bone integration. .Promimic's products find their applications primarily in the orthopedic and dental implant markets, aiming to improve patient outcomes through enhanced healing processes. The company's innovative approach to biomaterials positions it as a key player in the medical implant industry, providing solutions that cater to the increasing demand for advanced osseointegration technologies. The company is headquartered in Mölndal, Sweden, and its shares are listed on the Nasdaq First North Growth Market.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
PRO
Country
🇸🇪 Sweden